Taiwanese team develops Alzheimer's plasma biomarker tests; Molecule points to pregnancy-related heart disease;

> Scientists in Taiwan have come up with new plasma biomarker tests focused on immunomagnetic reduction to help detect the risk of Alzheimer's. Story (reg. req.)

> The VEGF protein appears to be an ineffective biomarker for advanced prostate cancer, Thomas Jefferson University researchers and colleagues have determined. Story

> Cambridge University spinoff CMOS Sensors in the U.K. developed a device that detects 35 different biomarkers in exhaled air at one part per million. Story

> The molecule miR-146a works as a biomarker for peripartum cardiomyopathy, or pregnancy-related heart disease, Belgian researchers have found. Its expression contributed to vascular damage in mouse studies. Item

> Dengue virus sufferers can benefit from a mast cell protein in the immune system whose presence appears to predict when people with the infection will develop major complications, Duke Medicine and Duke-National University of Singapore scientists believe. Release

> Ohio State researchers, relying on data from The Cancer Genome Atlas, now know of 37 RNA molecules that could help predict survival in patients with a common form of breast cancer. Item

Suggested Articles

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries.

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.